Skip Nav Destination
Issues
Association between Immune-Related Adverse Events and Atezolizumab in Previously Treated Patients with Unresectable Advanced or Recurrent Non–Small Cell Lung Cancer
Hidetoshi Hayashi; Makoto Nishio; Hiroaki Akamatsu; Yasushi Goto; Satoru Miura; Akihiko Gemma; Ichiro Yoshino; Toshihiro Misumi; Takashi Kijima; Naoto Takase; Masaki Fujita; Sadatomo Tasaka; Atsuto Mouri; Tetsuro Kondo; Kei Takamura; Yosuke Kawashima; Kazuyoshi Imaizumi; Shunichiro Iwasawa; Shintaro Nakagawa; Tetsuya Mitsudomi
Intraoperative Guidance of Pancreatic Cancer Resection Using a Toll-like Receptor 2–Targeted Fluorescence Molecular Imaging Agent
Amanda S. Huynh; Allison S. Cohen; Michael Doligalski; Todd J. Casagni; Valerie E. Moberg; Xuan Huang; Jennifer Morse; Dominique Abrahams; Mark C. Lloyd; Barbara A. Centeno; Margaret K. Baldwin; Mark L. McLaughlin; Josef Vagner; David L. Morse
Functional RNAi Screening Identifies G2/M and Kinetochore Components as Modulators of TNFα/NF-κB Prosurvival Signaling in Head and Neck Squamous Cell Carcinoma
Ethan L. Morgan; Anthony D. Saleh; Shaleeka Cornelius; Sophie G. Carlson; Tiffany Toni; Hui Cheng; Jun Jeon; Ramya Viswanathan; Xinping Yang; Christopher Silvin; Paul E. Clavijo; Anastasia L. Sowers; James B. Mitchell; Pinar Ormanoglu; Madhu Lal Nag; Scott E. Martin; Zhong Chen; Carter Van Waes
Region-Based Analyses of Existing Genome-Wide Association Studies Identifies Novel Potential Genetic Susceptibility Regions for Glioma
Karen Alpen; Robert J. Maclnnis; Claire M. Vajdic; John Lai; James G. Dowty; Eng-Siew Koh; Elizabeth Hovey; Rosemary Harrup; Tuong L. Nguyen; Shuai Li; David Joseph; Geza Benke; Pierre-Antoine Dugué; Melissa C. Southey; Graham G. Giles; Anna K. Nowak; Katharine J. Drummond; Daniel F. Schmidt; John L. Hopper; Miroslaw K. Kapuscinski; Enes Makalic
The Significance of Comprehensive Metabolic Phenotypes in Cancer Risk: A Japan Multi-Institutional Collaborative Cohort Study
Takeshi Watanabe; Tien Van Nguyen; Sakurako Katsuura-Kamano; Kokichi Arisawa; Masashi Ishizu; Taichi Unohara; Keitaro Tanaka; Chisato Shimanoe; Mako Nagayoshi; Takashi Tamura; Yuko Kubo; Yasufumi Kato; Isao Oze; Hidemi Ito; Nobuaki Michihata; Yohko Nakamura; Shiroh Tanoue; Chihaya Koriyama; Sadao Suzuki; Hiroko Nakagawa-Senda; Teruhide Koyama; Satomi Tomida; Kiyonori Kuriki; Naoyuki Takashima; Akiko Harada; Kenji Wakai; Keitaro Matsuo; for the J-MICC Study Group
ETx-22, a Novel Nectin-4–Directed Antibody–Drug Conjugate, Demonstrates Safety and Potent Antitumor Activity in Low-Nectin-4–Expressing Tumors
Marc Lopez; Emerence Crompot; Emmanuelle Josselin; Anne Farina; Marion Rubis; Remy Castellano; Joanna Fares; Maria Wehbe; Yves Collette; Emmanuelle Charafe; Stéphanie Blanchin; François Romagne; Anikó Pálfi; Torsten Hechler; Andreas Pahl; Hatem A. Azim, Jr; Florence Lhospice; Emilie Mamessier; François Bertucci; Jack Elands; Xavier Préville; Daniel Olive
Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSI
Jordan P. Hartig; Kaitlyn Bejar; Lyndsay E.A. Young; Grace Grimsley; Jennifer R. Bethard; Dean A. Troyer; Javier Hernandez; Jennifer D. Wu; Joseph E. Ippolito; Lauren E. Ball; Jonathan A.L. Gelfond; Teresa L. Johnson-Pais; Anand S. Mehta; Robin J. Leach; Peggi M. Angel; Richard R. Drake
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds